Vynleads, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Vynleads, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $49 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $484 | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $48.3K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $396.7K | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | $1.82M | Jun 11, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 24, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.5K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($14.9K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($35.6K) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($29.1K) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($32.0K) | Mar 21, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($255.1K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($261.2K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($263.4K) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($273.6K) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($271.6K) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($379.6K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($303.1K) | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | ($519.8K) | Jun 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($247.3K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($239.2K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($235.7K) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($261.2K) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($266.8K) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($372.3K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($298.6K) | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | ($519.0K) | Jun 11, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $240.8K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $224.3K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $200.2K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $232.1K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $234.8K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $362.9K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $278.2K | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | $756.8K | Jun 11, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($108.9K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($112.4K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($144.8K) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($123.7K) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($130.5K) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($112.7K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($32.7K) | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | ($262.0K) | Jun 11, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.7K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $87.2K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $36.4K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $24.3K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $25.4K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $38.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $112.4K | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | $172.5K | Jun 11, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $406.1K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $314.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $805.3K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $659.8K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $517.3K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $388.3K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $247.8K | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | $121.8K | Jun 11, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($352.4K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($227.4K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($768.9K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($635.5K) | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | ($491.9K) | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | ($350.3K) | Mar 21, 2023 |
| FY2021 | Dec 31, 2019 | ($135.4K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $50.7K | Apr 7, 2021 |
| FY2019 | Dec 31, 2017 | $508.2K | Jun 11, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.04M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.79M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.52M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($2.26M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($1.99M) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($1.72M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($1.34M) | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | ($1.03M) | Jun 11, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $69.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.5K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $503 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.7K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $7.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $63.4K | Apr 7, 2021 |
| FY2020 | Dec 31, 2018 | $21.1K | Apr 7, 2021 |
| FY2019 | Dec 31, 2017 | $136.0K | Jun 11, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 24, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 21, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 21, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.33M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 18.33M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 11.60M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 11.60M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 11.60M | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | 11.60M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 11.40M | Apr 7, 2021 |
| FY2019 | Dec 31, 2018 | 13.40M | Jun 11, 2020 |